(Q36360521)

13 August 2017

1 reference

title

Alphavbeta6 integrin in wound healing and cancer of the oral cavity (English)

1 reference

13 August 2017

1 reference

Thomas GJ

1

1 reference

PubMed ID

16393247

13 August 2017

Nyström ML

series ordinal

2

1 reference

PubMed ID

16393247

13 August 2017

Marshall JF

series ordinal

3

1 reference

13 August 2017

1 January 2006

1 reference

Journal of Oral Pathology & Medicine

13 August 2017

1 reference

13 August 2017

35

1 reference

13 August 2017

1-10

1 reference

13 August 2017

1

1 reference

Integrins: versatility, modulation, and signaling in cell adhesion

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrins: bidirectional, allosteric signaling machines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Epithelial integrin alpha 6 beta 4: complete primary structure of alpha 6 and variant forms of beta 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrin regulation of growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

The integrin alphaVbeta6 binds and activates latent TGFbeta3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratinocyte migration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Transforming Growth Factor-β-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in β6−/− Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Expression of integrins in human gingiva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Re-epithelialization of normal human excisional wounds is associated with a switch from alpha v beta 5 to alpha v beta 6 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Keratinocytes in human wounds express alpha v beta 6 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Immunolocalization of tenascin-C, alpha9 integrin subunit, and alphavbeta6 integrin during wound healing in human oral mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Differential effects of the integrins alpha9beta1, alphavbeta3, and alphavbeta6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Tenascins: regulation and putative functions during pathological stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Matrix metalloproteinases: their function in tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Expression of alpha(v)beta6 integrin in oral leukoplakia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Expression of αv Integrin Family in Gastric Carcinomas: Increased αvβ6 is Associated with Lymph Node Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Beta-6 Integrin, tenascin-C, and MMP-1 expression in salivary gland neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Expression of integrin beta 6 enhances invasive behavior in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrin expression in colon cancer cells is regulated by the cytoplasmic domain of the beta6 integrin subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Alphavbeta6-Fyn signaling promotes oral cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Modulation of the urokinase-type plasminogen activator receptor by the beta6 integrin subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Role of transforming growth factor Beta in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

TGF-beta signaling: positive and negative effects on tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Genetic events and the role of TGF beta in epithelial tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrin expression in human melanoma cells with differing invasive and metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Demystified...recombinant antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Antibody phage display technology and its applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Natural and designer binding sites made by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Rapid solid phase synthesis and biodistribution of 18F-labelled linear peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Pegylation: engineering improved biopharmaceuticals for oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Role of the alpha(v)beta6 integrin in human oral squamous cell carcinoma growth in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Gene-based vaccines and immunotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Modifying adenoviral vectors for use as gene-based cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Adenovirus vectors targeting alphaV integrin or heparan sulfate receptors display different distribution of transgene activity after intramuscular injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Transforming growth factor-beta 1 modulates beta 1 and beta 5 integrin receptors and induces the de novo expression of the alpha v beta 6 heterodimer in normal human keratinocytes: implications for wound healing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2005.00374.X

10.1111/J.1600-0714.2005.00374.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16393247